German researchers argue children may act as a 'brake' on coronavirus infections

As the debate about reopening American schools in the fall rages on, a new study conducted by the Dresden University Hospital in Germany could shed some light on the matter.
The study, the largest of its kind in Germany, tested more than 2,000 students and teachers at 13 schools in three different districts in Saxony, the only German state to reopen schools with full class sizes in May. The results showed only 12 participants tested positive for COVID-19 antibodies, five of whom had previously tested positive for the active virus, suggesting the schools did not play a major role in spreading the virus. Indeed, they may have even helped curb transmission.
"Children act more as a brake on infection," said Prof. Reinhard Berner, the head of pediatric medicine at Dresden University Hospital and leader of the study. "Not every infection that reaches them is passed on."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There are several caveats, however. For starters, Saxony has had a lower infection rate overall than other parts of Germany during the pandemic, so it's natural the rate would be lower among subgroups, as well. Still, even if areas with larger epidemics are more cautious, the study could be useful for other places with fewer cases.
Another complication is the fact that while Saxony allowed for full classrooms, parents won the right to keep their children home, so it's unclear if schools were really operating at full capacity.
Finally, a new study out of the United Kingdom suggests immunity to the novel virus wanes within months, so while that research warrants its own skepticism, it's possible more students in the German study were at one point infected but no longer produce antibodies. Read more at The Guardian and Yahoo News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
A wine-themed tour of beautiful Uruguay
The Week Recommends Secret paradise in South America boasts beautiful vineyards
By The Week UK Published
-
Romanian democracy: no place for the 'TikTok messiah' Calin Georgescu
Talking Point State is 'fighting back' against poster boy for right-wing conspiracists
By The Week UK Published
-
5 terrifically taxing cartoons about tariffs
Cartoons Artists take on rising prices, dumb ideas, and more
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published